Clinical Trial Update: Efficacy and Safety of Xepol (Human Immunoglobulin) in Subjects With Post-Polio Syndrome (PPS) [NA]

View source ↗

Summary

Completed clinical trial evaluating the efficacy and safety of Xepol, a human immunoglobulin, in persons with post-polio syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-polio Syndrome

Drugs mentioned

• Xepol (human immunoglobulin)

Snippet

Sponsor: Calliditas Therapeutics AB | Conditions: Post Polio Syndrome, PPS | NA | Status: COMPLETED